This opportunity is no longer accepting applications.
grant PAR-24-085

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

This grant opportunity is for research projects that conduct early phase clinical trials (Phase 0, I, and II) focused on cancer diagnostics and treatments. Projects must align with the goals of specific research programs, including cancer therapy, imaging, diagnosis, radiation research, complementary and alternative medicine, or HIV/AIDS-related cancer research. Applications can propose trials…

The purpose of this reissuance is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed proj…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: December 15, 2023
Open for Submission: December 15, 2023
Submission Deadline: January 7, 2027
Application Window Closes: January 7, 2027

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.